Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05704231
Other study ID # iremozdemir
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date February 1, 2023
Est. completion date June 1, 2024

Study information

Verified date January 2023
Source Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Contact IREM NUR ÖZDEMIR, PhD, RN.
Phone +905076472107
Email iremozdemir92@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will be carried out to examine the effect of telephone-assisted smoking cessation program on self-efficacy, smoking behavior, tumor recurrence and progression in patients with non-muscle invasive bladder cancer.


Description:

This study will be conducted to examine the effect of a telephone-assisted smoking cessation program (3 months) on self-efficacy, smoking behavior, tumor recurrence and progression for chronic disease management in patients diagnosed with non-muscle invasive bladder cancer. After 3 months of motivational interviewing was applied to the experimental group, the scales will be applied in the 3rd, 6th and 12th months. The cystoscopy will be performed at 3 and 12 months for tumor recurrence and progression


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date June 1, 2024
Est. primary completion date March 1, 2024
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - Being 21 years or older - First-time diagnosis of non-muscle invasive bladder cancer (patients with pTa urothelial cancer) - Chronic smoking for at least 1 year - At least primary school graduate and can speak Turkish - Having a smartphone and internet access - No communication barrier (speech, vision or hearing problem) - Individuals who agree to participate in the research. Exclusion Criteria: - Patients with positive CIS (carcinoma in situ) - Patients with minimal invasion of the lamina propria and above - Patients with extravesical extension - Patients with synchronous and metachronous tumors - Communication disability (speech, vision or hearing problem)

Study Design


Intervention

Behavioral:
Behavioral: Motivational Interviewing with WhatsApp video call
The intervention group will be given a motivational interview with a WhatsApp video call for 3 months. Motivational interviews will be applied every two weeks, 6 times in total.

Locations

Country Name City State
Turkey Irem Nur Ozdemir Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (4)

Spencer JC, Wheeler SB. A systematic review of Motivational Interviewing interventions in cancer patients and survivors. Patient Educ Couns. 2016 Jul;99(7):1099-1105. doi: 10.1016/j.pec.2016.02.003. Epub 2016 Feb 8. — View Citation

Taylor KL, Williams RM, Li T, Luta G, Smith L, Davis KM, Stanton CA, Niaura R, Abrams D, Lobo T, Mandelblatt J, Jayasekera J, Meza R, Jeon J, Cao P, Anderson ED; Georgetown Lung Screening, Tobacco, and Health Trial. A Randomized Trial of Telephone-Based S — View Citation

Thomsen T, Tonnesen H, Okholm M, Kroman N, Maibom A, Sauerberg ML, Moller AM. Brief smoking cessation intervention in relation to breast cancer surgery: a randomized controlled trial. Nicotine Tob Res. 2010 Nov;12(11):1118-24. doi: 10.1093/ntr/ntq158. Epu — View Citation

Wakefield M, Olver I, Whitford H, Rosenfeld E. Motivational interviewing as a smoking cessation intervention for patients with cancer: randomized controlled trial. Nurs Res. 2004 Nov-Dec;53(6):396-405. doi: 10.1097/00006199-200411000-00008. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Self-efficacy for managing chronic disease 6-item scale. The scale is rated on a 10-point scale ranging from "not at all sure" to "very sure". The score obtained from the scale is the average of 6 items, and high scores indicate high self-efficacy. If more than one answer is given to an item and the items follow each other, the lower score is included in the calculation. In order to calculate the scale, at least 4 items must be answered. The Croncbach's alpha coefficient was 0.91 and the mean of the original scale was 5.17 ± 2.22. Turkish validity and reliability was done by Incirkus and Nahcivan (2020). The Cronbach's alpha coefficient of the scale was found to be 0.90. Change from chronic disease self-efficacy at 12 months
Primary Glover Nilsson Smoking Behavioral Questionnaire The Turkish validity and reliability of the scale was done by Sancar. The scale was created as a scale with 11 questions as a result of the Turkish adaptation study, and each question is scored from 0 to 4 with a 5-option scoring system. Behavioral addiction score below 12 is mild, 12 and 22 moderate, 23-33 strong, 33 above very strong behavioral addiction score has been suggested. The scale is a valid and reliable scale that can be used to determine the behavioral aspect of smoking addiction of smokers, both in its one-dimensional and 2-dimensional form. The Croncbach alpha coefficient was found to be 0.82. This value indicates that the scale is quite reliable in terms of internal consistency. The "Conditioning and Significance" sub-dimension of the scale consists of 5 items and the Cronbach's alpha coefficient is 0.762. The "Handling and Emotions" sub-dimension consists of 6 items and the Cronbach's alpha coefficient is 0.735. Change from smoking behavior at 12 months
Secondary Tumor Recurrence Tumor recurrence will be examined by cystoscopy at the 3rd and 12th months after the intervention. Change from tumor recurrence and progression at 12 months
Secondary Progression Progression will be examined by cystoscopy at the 3rd and 12th months after the intervention. Change from progression at 12 months
See also
  Status Clinical Trial Phase
Completed NCT05114187 - An Internet-Based Education Program for Care Partners of People Living With Dementia N/A
Completed NCT05655364 - Development of a Breastfeeding Supportive Mobile Application N/A
Completed NCT04428034 - Learning Skills Together Pilot Study N/A
Recruiting NCT05914766 - An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer N/A
Completed NCT06395857 - Visual Arts-based Intervention for Community-dwelling Stroke Survivors N/A
Not yet recruiting NCT05623202 - Pilot Study of Capacity-oriented Intervention to Promote Food Security and Diet Quality Among Hispanics/Latinos N/A
Enrolling by invitation NCT02391766 - Group Intervention Empowerment Dementia Phase 0
Completed NCT01179854 - Remegal Different Doses in Patients With Refractory Partial Seizures Phase 2
Recruiting NCT06024083 - Skills Video Intervention for Chinese/Chinese Americans N/A
Completed NCT06384612 - The Effect Of The Use Of Pocket Cards In An Undergraduate Nursıng N/A
Completed NCT04087551 - Development of the Balance Recovery Falls-Efficacy Scale for the Community-dwelling Older Adults N/A
Recruiting NCT05512624 - Integrating a Mental Health Intervention Into Primary Health Care for Refugees N/A
Completed NCT04633434 - Evaluation Study of Talk Parenting Skills N/A
Not yet recruiting NCT04493944 - Edible Seaweeds and Health: Quality Biomarkers to Support Consumer Acceptance N/A
Completed NCT04867005 - Advance Care Planning in Primary Care: a Cluster Randomized Clinical Trial N/A
Completed NCT04161820 - The Effect of Education Based on the Chronic Care Model (StrokeCARE) in Patients With Ischemic Stroke N/A
Completed NCT06082895 - The Effect of Motivational Interviewing Method on Birth Self-efficacy N/A
Completed NCT05574764 - ABC Mental Health: A Behavioral Study of K-12 Teachers and School Staff N/A
Completed NCT03758027 - CARESS: An Investigation of Effects of CARESS N/A
Completed NCT04911504 - The Effects of Resilience and Self-efficacy on Nurses' Compassion Fatigue